Reference Interval:
18 years or older: 0-1 ng/mL
|
| Interpretive Data: |
The Beckman Coulter Access DxI AFP method is used. Results obtained with different assay methods or kits cannot be used interchangeably. AFP is a valuable aid in the management of nonseminomatous testicular cancer patients when used in conjunction with information available from the clinical evaluation and other diagnostic procedures. Increased AFP concentrations have also been observed in ataxia telangiectasia, hereditary tyrosinemia, primary hepatocellular carcinoma, teratocarcinoma, gastrointestinal tract cancers with and without liver metastases, and in benign hepatic conditions such as acute viral hepatitis, chronic active hepatitis, and cirrhosis. The result cannot be interpreted as absolute evidence of the presence or absence of malignant disease. The result is not interpretable as a tumor marker in pregnant females. This test is FDA cleared but is not labeled for use with CSF.
See Compliance Statement B: www.aruplab.com/CS
|
| CPT Code(s): |
86316
|
Cross References: |
AFP (Alpha Fetoprotein, CSF (Tumor Marker)) |
|
